Chronic Eosinophilic Leukemia: Diagnosis and Therapy

Autor:	Andreas Reiter, William Shomali, Jason Gotlib
Rok vydání:	2021
Předmět:	Cancer Research Chronic eosinophilic leukemia business.industry Not Otherwise Specified Hematology Molecular Genetic Abnormality medicine.disease World health Oncology Immunology medicine Peripheral Blood Eosinophilia business Interferon alfa medicine.drug
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 21:S27-S29
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(21)01197-6
Popis:	Introduction In the 2017 World Health Organization (WHO) classification, chronic eosinophilic leukemia, not otherwise specified (CEL, NOS), is included as one of 7 distinct diagnostic entities under the major category of myeloproliferative neoplasms (MPNs).1 WHO defining criteria for CEL, NOS include: (a) peripheral blood eosinophilia >1.5×109/L; (b) evidence of clonal cytogenetic or molecular genetic abnormality, and/or (c) presence of excess myeloblasts (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4f0531c1393d477540478e4d9c251c06 https://doi.org/10.1016/s2152-2650(21)01197-6 Zobrazit plný text záznamu Full Text from ScienceDirect